Looking beneath the surface: The cell death pathway of Fas/APO-1 (CD95)

Molecular Medicine

Volumn 2, Issue 1, 1996, Pages 7-20

  Stanger, Ben Z ^a,b  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; FAS ANTIGEN;

ARTICLE; CAENORHABDITIS ELEGANS; CELL DEATH; CELL STRUCTURE; CELL SURFACE; CYTOTOXICITY; DROSOPHILA; EVOLUTION; GENE EXPRESSION; GENETIC SELECTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

EID: 0029669175     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03402198     Document Type: Article

References (112)

1. Saunders JW. (1966) Death in embryonic systems. Science 154: 604-612.
2. Wyllie AH, Kerr JFR, Currie AR. (1980) Cell death: The significance of apoptosis. Int. Rev. Cytol. 68: 251-306.
3. Ellis HM, Horvitz HR. (1986) Genetic control of programmed cell death in the nematode C. elegans. Cell 44: 817-829.
4. Abrams JM, White K, Fessler LI, Steller H. (1993) Programmed cell death during Drosophila embryogenesis. Development 117: 29-43.
5. Raff M. (1992) Social controls on cell survival and cell death. Nature 356: 397-400.
6. Trauth BC, Klas C, Peters AMJ, et al. (1989) Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245: 301-305.
7. Yonehara S, Ishii A, Yonehara M. (1989) A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169: 1747-1756.
8. Itoh N, Yonehara S, Ishii A, et al. (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66: 233-243.
9. Oehm A, Behrmann I, Falk W, et al. (1992) Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. J. Biol. Chem. 267: 10709-10715.
10. Smith CA, Farrah T, Goodwin RG. (1994) The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death. Cell 76: 959-962.
11. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. (1992b) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314-317.
12. Suda T, Takahashi T, Golstein P, Nagata S. (1993) Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75: 1169-1178.
13. Takahashi T, Tanaka M, Brannan CI, et al. (1994) Generalized lymphoproliferative disease in mice caused by a point mutation in the Fas ligand. Cell 76: 969-976.
14. Lynch DH, Watson ML, Alderson MR, et al. (1994) The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1: 131-136.
15. Ashwell JD, Cunningham RE, Noguchi PD, Hernandez D. (1987) Cell growth cycle block of T cell hybridomas upon activation with antigen. J. Exp. Med. 165: 173-194.
16. Singer GG, Abbas AK. (1994) The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1: 365-371.
17. Russell JH, Rush B, Weaver C, Wang R. (1993) Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc. Natl. Acad. Sci. U.S.A. 90: 4409-4413.
18. Dhein J, Walczak H, Baumler C, Debatin K-M, Krammer PH. (1995) Autocrine T-cell suicide by APO-1/(Fas/CD95). Nature 373: 438-441.
19. Brunner T, Mogil RJ, LaFace D, et al. (1995) Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373: 441-444.
20. Ju S-T, Panka DJ, Cui H, et al. (1995) Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373: 444-448.
21. Rothstein TL, Wang JKM, Panka DJ, et al. (1995) Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 374: 163-165.
22. + cells. Nature 376: 181-184.
23. Cohen PL, Eisenberg RA. (1991) Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol 9: 243-269.
24. Henkart PA. (1994) Lymphocyte-mediated cytotoxicity: Two pathways and multiple effector molecules. Immunity 1: 343-346.
25. Ogasawara J, Watanabe-Fukunaga R, Adachi M, et al. (1993) Lethal effect of the anti-Fas antibody in mice. Nature 364: 806-809.
26. Adachi M, Suematsu S, Kondo T, et al. (1995) Targeted mutation in the Fas gene causes hyperplasia of peripheral lymphoid organs and liver. Nature Genet. 11: 294-300.
27. Leist M, Gantner F, Kunstle G, et al. (1996) The 55-kD tumor necrosis factor receptor and CD95 independently signal murine hepatocyte apoptosis and subsequent liver failure. Mol. Med. 2: 109-124.
28. Cheng J, Zhou T, Liu C, et al. (1994) Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263: 1759-1762.
29. Fisher GH, Rosenberg FJ, Straus SE, et al. (1995) Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81: 935-946.
30. Rieux-Laucat F, Le Deist F, Hivroz C, et al. (1995) Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268: 1347-1349.
31. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC. (1995) A role for CD95 ligand in preventing graft rejection. Nature 377: 630-632.
32. + T cells from human immunodeficiency virus-infected asymptomatic individuals. J. Exp. Med. 175: 331-340.
33. Katsikis PD, Wunderlich ES, Smith CA, Herzenberg LA, Herzenberg LA. (1995) Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J. Exp. Med. 181: 2029-2036.
34. Westendorp MO, Frank R, Ochsenbauer C, et al. (1995) Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375: 497-500.
35. Itoh N, Nagata S. (1993) A novel protein domain required for apoptosis. J. Biol. Chem. 268: 10932-10937.
36. Tartaglia LA, Ayres TM, Wong GHW, Goeddel DV. (1993b) A novel domain within the 55 kd TNF receptor signals cell death. Cell 74: 845-853.
37. Schlessinger J. (1988) Signal transduction by allosteric receptor oligomerization. Trends Biochem. Sci. 13: 443-447.
38. Dhein J, Daniel PT, Trauth BC, Oehm A, Moller P, Krammer PH. (1992) Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. J. Immunol. 149: 3166-3173.
39. Banner DW, D'Arcy A, Janes W, et al. (1993) Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: implications for TNF receptor activation. Cell 73: 431-445.
40. Clement M-V, Stamenkovic I. (1994) Fas and tumor necrosis factor receptor-mediated cell death: Similarities and distinctions. J. Exp. Med. 180: 557-567.
41. Bazzoni F, Alejos E, Beutler B. (1995) Chimeric tumor necrosis factor receptors with constitutive signaling activity. Proc. Natl. Acad. Sci. U.S.A. 92: 5376-5380.
42. Fields S, Song O. (1989) A novel genetic system to detect protein-protein interactions. Nature 340: 245-246.
43. Boldin MP, Mett IL, Varfolomeev EE, et al. (1995a) Self-association of the "death domains" of the p55 tumor necrosis factor (TNF) receptor and Fas/APO1 prompts signaling for TNF and Fas/APO1 effects. J. Biol. Chem. 270: 387-391.
44. Stanger BZ, Leder P, Lee T-H, Kim E, Seed B. (1995) RIP: A novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 81: 513-523.
45. Song HY, Dunbar JD, Donner DB. (1994) Aggregation of the intracellular domain of the type 1 tumor necrosis factor receptor defined by the two-hybrid system. J. Biol. Chem. 269: 22492-22495.
46. Hsu H, Xiong J, Goeddel DV. (1995) The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 81: 495-504.
47. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D. (1995b) A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J. Biol. Chem. 270: 7795-7798.
48. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM. (1995) FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81: 505-512.
49. Golstein P, Marguet D, Depraetere V. (1995) Homology between Reaper and the cell death domains of Fas and TNFR1. Cell 81: 185-186.
50. White K, Grether ME, Abrams JM, Young L, Farrell K, Steller H. (1994) Genetic control of programmed cell death in Drosophila. Science 264: 677-693.
51. Cleveland JL, Ihle JN. (1995) Contenders in FasL/TNF death signaling. Cell 81: 479-482.
52. Schulze-Osthoff K, Walczak H, Droge W, Krammer PH. (1994b) Cell nucleus and DNA fragmentation are not required for apoptosis. J. Cell. Biol. 127: 15-20.
53. Nakajima H, Golstein P, Henkart PA. (1995) The target cell nucleus is not required for cell-mediated granzyme- or Fas-based cytotoxicity. J. Exp. Med. 181: 1905-1909.
54. Owen-Schaub LB, Yonehara S, Crump WLd, Grimm EA. (1992) DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell. Immunol. 140: 197-205.
55. Klas C, Debatin K-M, Jonker RR, Krammer PH. (1993) Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 5: 625-630.
56. Heldin C-H. (1995) Dimerization of cell surface receptors in signal transduction. Cell 80: 213-223.
57. Kolesnick R, Golde DW. (1994) The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77: 325-328.
58. Kyriakis JM, Banerjee P, Nikolakaki E, et al. (1994) The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369: 156-160.
59. Derijard B, Hibi M, Wu IH, et al. (1994) JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76: 1025-1037.
60. Darnay BG, Reddy SAG, Aggarwal BB. (1994a) Identification of a protein kinase associated with the cytoplasmic domain of the p60 tumor necrosis factor receptor. J. Biol. Chem. 269: 20299-20304.
61. Darnay BG, Singh S, Chaturvedi MM, Aggarwal BB. (1995) The p60 tumor necrosis factor (TNF) receptor-associated kinase (TRAK) binds residues 344-397 within the cytoplasmic domain involved in TNF signaling. J. Biol. Chem. 270: 14867-14870.
62. Eischen CM, Dick CJ, Leibson PJ. (1994) Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis. J. Immunol. 153: 1947-1954.
63. Schulze-Osthoff K, Krammer PH, Droge W. (1994a) Divergent signalling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. EMBO J. 13: 4587-4596.
64. Sato T, Irie S, Kitada S, Reed JC. (1995) FAP-1: A protein tyrosine phosphatase that associates with Fas. Science 268: 411-415.
65. Feng X-H, Zhao Y, Bottino PJ, Kung S-D. (1993) Cloning and characterization of a novel member of protein kinase family from soybean. Biochim. Biophys. Acta 1172: 200-204.
66. Hubbard SR, Wei L, Ellis L, Hendrickson WA. (1994) Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature 372: 746-754.
67. Maekawa K, Imagawa N, Nagamatsu M, Harada S. (1994) Molecular cloning of a novel protein-tyrosine phosphatase containing a membrane-binding domain and GLGF repeats. FEBS Lett. 337: 200-206.
68. Su X, Zhou T, Wang Z, Yang P, Jope RS, Mountz JD. (1995) Defective expression of hematopoietic cell protein tyrosine phosphatase (HCP) in lymphoid cells blocks Fas-mediated apoptosis. Immunity 2: 353-362.
69. Shultz LD, Schweitzer PA, Rajan TV, et al. (1993) Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 73: 1445-1454.
70. Cifone MG, R DeMaria, Roncaioli P, et al. (1994) Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J. Exp. Med. 180: 1547-1552.
71. Gill BM, Nishikata H, Chan D, Delovitch TL, Ochi A. (1994) Fas antigen and sphingomyelin-ceramide turnover-mediated signaling: role in life and death of T lymphocytes. Immunol. Rev. 142: 113-126.
72. Obeid LM, Linardic CM, Karolak LA, Hannun Y. (1993) Programmed cell death induced by ceramide. Science 259: 1769-1771.
73. Jarvis WD, Kolesnick RN, Fornari FA, Traylor RS, Gewirtz DA, Grant S. (1994) Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc. Natl. Acad. Sci. U.S.A. 91: 73-77.
74. Jaattela M, Benedict M, Tewari M, Shayman JA, Dixit VM. (1995) Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogene 10: 2297-2305.
75. Gulbins E, Bissonnette R, Mahboubi A, et al. (1995) Fas-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. Immunity 2: 341-351.
76. Liu J, Mathias S, Yang Z, Kolesnick RN. (1994) Renaturation and tumor necrosis factor-α stimulation of a 97-kDa ceramide-activated protein kinase. J. Biol. Chem. 269: 3047-3052.
77. Alderson MR, Armitage RJ, Maraskovsky E, et al. (1993) Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med. 178: 2231-2235.
78. Mapara MY, Bargou R, Zugck C, et al. (1993) APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: Correlation with bcl-2 oncogene expression. Eur. J. Immunol. 23: 702-708.
79. Owen-Schaub LB, Radinsky R, Kruzel E, Berry K, Yonehara S. (1994) Anti-Fas on nonhematopoietic tumors: Levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. Cancer Res. 54: 1580-1586.
80. Aggarwal BB, Singh S, Lapushin R, Totpal K. (1995) Fas antigen signals proliferation of normal human diploid fibroblasts and its mechanism is different from tumor necrosis factor receptor. FEBS Lett. 364: 5-8.
81. Hengartner MO, Horvitz HR. (1994) C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell 76: 665-676.
82. Vaux DL, Haecker G, Strasser A. (1994) An evolutionary perspective on apoptosis. Cell 76: 777-779.
83. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR. (1993) The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell 75: 641-652.
84. Thornberry NA, Bull HG, Calaycay JR, et al. (1992) A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 356: 768-774.
85. Martin SJ, Green DR. (1995) Protease activation during apoptosis - Death by a thousand cuts. Cell 82: 349-352.
86. Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J. (1993) Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75: 653-660.
87. Shi L, Kam C-M, Powers JC, Aebersold R, Greenberg AH. (1992b) Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions. J. Exp. Med. 176: 1521-1529.
88. Shi L, Kraut RP, Aebersold R, Greenberg AH. (1992a) A natural killer cell granule protein that induces DNA fragmentation and apoptosis. J. Exp. Med. 175: 553-566.
89. Darmon AJ, Nicholson DW, Bleackley RC. (1995) Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature 377: 446-448.
90. Tewari M, Dixit VM. (1995) Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J. Biol. Chem. 270: 3255-3260.
91. Enari M, Hug H, Nagata S. (1995) Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375: 78-81.
92. Los M, Van de Craen M, Penning LC, et al. (1995) Requirement of an ICE/CED-3 protease for Fas/APO-1 mediated apoptosis. Nature 375: 81-83.
93. Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC. (1994) Cleavage of poly (ADP-ribose) polymerase by a proteinase with porperties like ICE. Nature 371: 346-347.
94. Tewari M, Quan LT, O'Rourke K, et al. (1995) Yama/CPP32b, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly-(ADP-ribose) polymerase. Cell 81: 801-809.
95. Nicholson DW, Ali A, Thornberry NA, et al. (1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37-43.
96. Kuida K, Lippke JA, Ku G, et al. (1995) Altered cytokine export and apoptosis in mice deficient in interleukin-1-beta converting enzyme. Science 267: 2000-2003.
97. Li P, Allen H, Banerjee S, et al. (1995) Mice deficient in IL-1-beta-converting enzyme are defective in production of mature IL-1-beta and resistant to endotoxic shock. Cell 80: 401-411.
98. Oltvai ZN, Korsmeyer SJ. (1994) Checkpoints of dueling dimers foil death wishes. Cell 79: 189-192.
99. Hengartner MO, Ellis RE, Horvitz HR. (1992) Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature 356: 494-499.
100. Itoh N, Tsujimoto Y, Nagata S. (1993) Effect of bcl-2 on Fas antigen-mediated cell death. J. Immunol. 151: 621-627.
101. Takayama S, Sato T, Krajewski S, et al. (1995) Cloning and functional analysis of BAG-1: A novel Bcl-2-binding protein with anti-cell death activity. Cell 80: 279-284.
102. Boise LH, Minn AJ, Noel PJ, et al. (1995) CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity 3: 87-98.
103. White E, Sabbatini P, Debbas M, Wold WSM, Kusher DI, Gooding LR. (1992) The 19-kilodalton Adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor α. Mol. Cell. Biol. 12: 2570-2580.
104. Hashimoto S, Ishii A, Yonehara S. (1991) The E1b oncogene of adenovirus confers cellular resistance to cytotoxicity of tumor necrosis factor and monoclonal anti-Fas antibody. Int. Immunol. 3: 343-351.
105. Chiou S-K, Tseng C-C, Rao L, White E. (1994) Functional complementation of the Adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells. J. Virol. 68: 6553-6566.
106. Beidler DR, Tewari M, Friesen PD, Poirier G, Dixit VM. (1995) The baculovirus p35 protein inhibits Fas- and tumor necrosis factor-induced apoptosis. J. Biol. Chem. 270: 16526-16528.
107. Bump NJ, Hackett M, Hugunin M, et al. (1995) Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science 269: 1885-1888.
108. Williams GT, Smith CA. (1993) Molecular regulation of apoptosis: Genetic controls on cell death. Cell 74: 777-779.
109. Tian Q, Streuli M, Saito H, Schlossman SF, Anderson P. (1991) A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells. Cell 67: 629-639.
110. Tian Q, Taupin J-L, Elledge S, Robertson M, Anderson P. (1995) Fas-activated serine/threonine kinase (FAST) phosphorylates TIA-1 during Fas-mediated apoptosis. J. Exp. Med. 182: 865-874.
111. Taupin J-L, Tian Q, Kedersha N, Robertson M, Anderson P. (1995) The RNA-binding protein TIAR is translocated from the nucleus to the cytoplasm during Fas-mediated apoptotic cell death. Proc. Natl. Acad. Sci. U.S.A. 92: 1629-1633.
112. Wong GHW, Goeddel DV. (1994) Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways. J. Immunol. 152: 1751-1755.